Copyright © 2024 B10 Health Technologies Private Limited
Research at Pi Health
Medical Research
About Department:
Pi Health Cancer Hospital – Research Department (PHCH-RD) was established in 2023. The Research Vision of PHCH-RD is to advance and excel in clinical research and to enhance and support patient care and treatment. At PHCH-RD, we conduct various types of research projects, such as Pharma-sponsored, Investigator–initiated and Academic research. These projects are supplemented by large-scale organizational projects, population-based epidemiologic studies, community-based intervention programs, multicentre controlled clinical trials, and research training programs.
Special features of PHCH-RD:
- Qualified and GCP (Good Clinical Practice) trained Research Investigators with a dedicated and full time GCP trained Research Team.
- Adequate working area with facilities for storage, audit and archival of research related activities
- Updated SOPs in compliance with national and international regulations.
Research activities at PHCH-RD cover the following main area of scientific and clinical interest:
Centre for Cancer: We conduct research on various types of cancers, such as breast, lung, colon, prostate, and blood cancers.
We explore the molecular mechanisms, risk factors, prevention strategies, diagnosis methods, and treatment options for these cancers. We also collaborate with other national and international organizations to conduct clinical trials and epidemiological studies.
The primary goals of our department at Pi Health Cancer Hospital are to:
- Define research directions, priorities, and focus areas.
- Regularly assess the advancements in Scientific and Clinical Research Projects.
- Propose and evaluate Research Proposals within our institution and in collaboration with National and International Organizations.
- Review the feasibility and oversee the execution of sponsored Research Proposals (Pharma Sponsored, Govt Sponsored, etc.) at our institute.
General Information:
Clinical studies help to bridge research and patient care by evaluating therapies, drugs and diagnostic tools to pave the way for discoveries that might benefit human patients in future.
Clinical trials test the safety and effectiveness of drugs and devices. They are usually sponsored by pharmaceutical companies and conducted by research teams of doctors and other medical professionals. Clinical trials have four phases:
- Phase I tests the medication on healthy people to check for any adverse or toxic effects and to ensure its safety for human use.
- Phases II and III assess the safety, effectiveness, and dosage of the medication. The drug or device is approved by the country drug regulator after these phases.
- Phase IV collects more information for previously approved treatments.
All the phases in clinical trials follow strict protocols and are overseen by many regulatory bodies, from the Drug Controller General of India to Institutional Ethics Committee (IEC). IECs (Institutional Ethics Committee) are a group of independent medical experts, ethicists, and lay persons. Researchers report to the IEC regularly about the entire conduct of the study, including the tests, results, and side effects.